Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from ...

Five women in Rajasthan seeking help after alleged postpartum kidney failure have drawn attention to postpartum acute kidney ...

Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist ...

Can hot weather harm your kidneys? Experts explain how heatwaves can increase the risk of dehydration, kidney stones, and ...

CT angiography of the abdomen showed occlusion of the proximal left main renal artery with global hypoperfusion of the left kidney (arrow). A ...

Five women from Rajasthan's Kota suffering from postpartum kidney failure have refused to continue dialysis and intensified ...

Dimerix has bought an acute kidney injury (AKI) drug from Mission Therapeutics, paying (PDF) $5 million upfront and ...

Sponsors educational summit of leading pediatric AKI health care experts Announces best practices webinar to further advance new treatment ...

A homemaker's extreme diet, fueled by unregulated weight loss trends, led to acute kidney injury. For three months, she consumed massive amounts of green vegetable juices, causing oxalate crystals to ...

Increases in serum creatinine similar to patients who received usual care ...